JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on March 14, 2008
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
283/11/7109    most recent
M708751200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grossmann, C.
Right arrow Articles by Gekle, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grossmann, C.
Right arrow Articles by Gekle, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print January 8, 2008
J. Biol. Chem, 10.1074/jbc.M708751200
Submitted on October 23, 2007
Revised on January 4, 2008
Accepted on January 8, 2008

EF-domains are sufficient for nongenomic mineralocorticoid receptor actions

Claudia Grossmann, Ruth Freudinger, Sigrid Mildenberger, Britta Husse, and Michael Gekle

Julius-Bernstein-Institut für Physiologie, University of Halle-Wittenberg, Halle (Saale) 06112

Corresponding Author: michael.gekle{at}medizin.uni-halle.de

The mineralocorticoid receptor (MR) is important for salt homeostasis and renocardiovascular pathophysiology. Signaling mechanisms include beside classical genomic pathways also nongenomic pathways with putative pathophysiological relevance, involving mitogen-activated protein kinases ERK1/2. We determined MR-domains required for nongenomic signaling and their potential to elicit pathophysiological effects in cultured cells under defined conditions. Expression of full length human MR or truncated MR consisting of the domains CDEF (MRCDEF), DEF (MRDEF) or EF (MREF) renders cells responsive for the MR-ligand aldosterone with respect to nongenomic ERK1/2-phopshorylation, whereas only full length MR and MRCDEF conferred genomic responsiveness. ERK1/2- phopsphorylation depends on EGF receptor and cSRC kinase. MREF expression is sufficient to evoke the aldosterone induced increase of collagen III abundance similar to full length MR expression. Our data suggest that nongenomic MR signaling is mediated by the EF domains and present the first proof of principle showing that nongenomic signaling can be sufficient for some pathophysiological effects. The minimum amino acid motif required for nongenomic MR signaling and its importance for the various effects has to be determined.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.